Literature DB >> 32339549

Neuroprotective effect of different physical exercises on cognition and behavior function by dopamine and 5-HT level in rats of vascular dementia.

Linlin Zhang1, Yongzhao Fan2, Xiaoyang Kong3, Wu Hao4.   

Abstract

The aim of the present study is to evaluate neuroprotective effect of different physical exercises on cognition and behavior function by dopamine and 5-HT in rats of vascular dementia. Forty Sprague-Dawley rats were enrolled in this study and randomly divided into following 5 groups: control group (C group, n = 8), vascular dementia group (VD group, n = 8), treadmill exercise and vascular dementia group (TE-VD group, n = 8), in-voluntary exercise and vascular dementia group (IE-VD group, n = 8), voluntary exercise and vascular dementia group (VE-VD group, n = 8). The rats in TE-VD, IE-VD and VE-VD groups were received different physical exercise interventions, treadmill exercise, voluntary running exercise, involuntary running exercise respectively, total 4 weeks. Next, the rats in VE-VD, IE-VD, TE-VD and VD groups were received bilateral common carotids arteries operation to create vascular dementia model. Then, we use a passive avoid test to evaluate cognition and open field test to evaluate cognition autonomic activity in each group. The level in hippocampal dopamine and 5-HT were detected by microdialysis coupled with high performance liquid chromatography. Behavior results demonstrated that: compared with C group, the cognition in VD group significantly decreased (p < 0.001); compared with VD group, the cognition in VE-VD, IE-VD and TE-VD groups were significantly increased (p < 0.001). However, there are no significant difference between VE-VD, IE-VD and TE-VD groups (p> 0.05). In addition, hippocampal dopamine and 5-HT level significantly decreased in VD group when compared with C group (p < 0.001); hippocampal dopamine and 5-HT level in VE-VD, IE-VD and TE-VD groups were significantly increased when compared with VD group (p < 0.05). However, there are no significant difference between VE-VD, IE-VD and TE-VD groups (p> 0.05). Therefore, we concluded that different physical exercises, included treadmill exercise, in-voluntary exercise and voluntary exercise, all can protect cognition by up-regulate dopamine and 5-HT level in rats of vascular dementia.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5-HT; Cognition; Dopamine; In-voluntary exercise; Treadmill exercise; Voluntary exercise

Mesh:

Substances:

Year:  2020        PMID: 32339549     DOI: 10.1016/j.bbr.2020.112648

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  5 in total

1.  Glibenclamide alters serotonin and dopamine levels in the rat striatum and hippocampus, reducing cognitive impairment.

Authors:  Alexander S Zubov; Irina S Ivleva; Nina S Pestereva; Tatiana V Tiutiunnik; Dmitrtii S Traktirov; Marina N Karpenko
Journal:  Psychopharmacology (Berl)       Date:  2022-05-11       Impact factor: 4.415

Review 2.  Understanding How Physical Exercise Improves Alzheimer's Disease: Cholinergic and Monoaminergic Systems.

Authors:  Boyi Zong; Fengzhi Yu; Xiaoyou Zhang; Wenrui Zhao; Peng Sun; Shichang Li; Lin Li
Journal:  Front Aging Neurosci       Date:  2022-05-18       Impact factor: 5.702

Review 3.  Metabolic Syndrome and Vascular-Associated Cognitive Impairment: a Focus on Preclinical Investigations.

Authors:  Trisha A Jenkins
Journal:  Curr Diab Rep       Date:  2022-06-23       Impact factor: 5.430

4.  Exercise on Striatal Dopamine Level and Anxiety-Like Behavior in Male Rats after 2-VO Cerebral Ischemia.

Authors:  Yongzhao Fan; Xiaoyang Kong; Kun Liu; Hao Wu
Journal:  Behav Neurol       Date:  2022-09-13       Impact factor: 3.112

5.  Ginkgolide B Alleviates Learning and Memory Impairment in Rats With Vascular Dementia by Reducing Neuroinflammation via Regulating NF-κB Pathway.

Authors:  Lijuan Huang; Yijie Shi; Liang Zhao
Journal:  Front Pharmacol       Date:  2021-06-17       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.